Pembrolizumab-induced toxic epidermal necrolysis: case report

A 63-year-old man with metastatic lung adenocarcinoma presented with biopsy confirmed toxic epidermal necrolysis (TEN). Symptoms commenced following 3 cycles of carboplatin, pemetrexed and pembrolizumab, with the first cycle given ~9.5 weeks prior to presentation. The patient was managed with immuno...

Descripción completa

Detalles Bibliográficos
Autores principales: Chow, Kar Ven Cavan, O’Leary, Connor, Paxton-Hall, Fiona, Lambie, Duncan, O’Byrne, Kenneth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931819/
https://www.ncbi.nlm.nih.gov/pubmed/35317001
http://dx.doi.org/10.1093/omcr/omac025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931819/
https://www.ncbi.nlm.nih.gov/pubmed/35317001
http://dx.doi.org/10.1093/omcr/omac025

Ejemplares similares